ETX.L - e-Therapeutics plc

LSE - LSE Delayed price. Currency in GBp
Currency in GBp

Valuation measures

Market cap (intra-day) 56.86M
Enterprise value 31.14M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)155.87
Price/book (mrq)102.00
Enterprise value/revenue 325.81
Enterprise value/EBITDA 6-0.22

Trading information

Stock price history

Beta (3Y monthly) -0.54
52-week change 3-68.24%
S&P500 52-week change 32.12%
52-week high 38.5000
52-week low 31.4000
50-day moving average 32.7819
200-day moving average 33.0918

Share statistics

Avg vol (3-month) 36.57M
Avg vol (10-day) 32.32M
Shares outstanding 5268.95M
Float 230.92M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Jan 2019
Most-recent quarter (mrq)31 Jan 2019

Profitability

Profit margin 0.00%
Operating margin (ttm)-11,579.54%

Management effectiveness

Return on assets (ttm)-33.05%
Return on equity (ttm)-45.60%

Income statement

Revenue (ttm)44k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)44k
EBITDA -5.04M
Net income avi to common (ttm)-4M
Diluted EPS (ttm)-1.5000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.9M
Total cash per share (mrq)0.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.39
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-3.7M
Levered free cash flow (ttm)-2.91M
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes